Guerbet

aka Guerbet SA, EPA:GBT

Guerbet is the French contrast-agent company behind Lipiodol, the iodised poppy-seed oil that radiologists use to deliver and image chemotherapy in liver tumours.

Guerbet, founded in 1926 and based near Paris, makes contrast agents and delivery systems for diagnostic and interventional imaging. Lipiodol (ethiodized oil), its oldest product, is used in transarterial chemoembolisation of hepatocellular carcinoma, where it carries the chemotherapy emulsion into the tumour and remains visible on computed tomography. Guerbet also sells iodinated and gadolinium contrast media, injectors and artificial-intelligence tools for liver and prostate imaging.

Headquarters

Villepinte, FR

Scorecard

All companies

#198of 1181 companies, score 24

modalities +2
regions +1
registry trials +21

0 approved, 0 in phase 3, 0 earlier, 0 targets, 108 registry studies. Formula on the scorecards page.

Type

imaging · EPA:GBT

Stage

Public

Website

www.guerbet.com/

Founded

1926

Products

1top

EstablishedOily iodinated contrast agent for hepatic arterial injection

Ethiodized oil · Lipiodol

Lipiodol is an iodine-rich oil injected into the liver's artery that lodges in liver tumours; it lets radiologists see them on CT and is the vehicle that carries chemotherapy into the tumour in conventional chemoembolisation for liver cancer.

Connected